Organization
Zhuhai Beihai Biotech
3 clinical trials
1 abstract
Clinical trial
A Phase I Study To Evaluate The Safety, Tolerability and Pharmacokinetics Of BH009 In Patients With Advanced Head And Neck Squamous (Non-nasopharyngeal) And Ovarian CancerStatus: Recruiting, Estimated PCD: 2024-03-30
Clinical trial
Phase I Clinical Trial of Safety, Tolerability and Pharmacokinetics of BH002 in Patients With Advanced Solid TumorsStatus: Completed, Estimated PCD: 2023-03-10
Clinical trial
An Open-label, Randomized, Single-dose, Two-period Cross-over Study to Evaluate the Relative Bioavailability Between BH006 for Injection Per the Intended Dosage Regimen and Fosaprepitant and Palonosetron in Healthy SubjectsStatus: Not yet recruiting, Estimated PCD: 2024-09-01